Breaking Finance News

Allergy Therapeutics PLC (LON:AGY) target price held steady at 37.00GBX, issued a report today by Numis

Yesterday Allergy Therapeutics PLC (LON:AGY) traded 3.65% higher at 21.25GBX. The company’s 50-day moving average is 18.82GBX and its 200-day moving average is 22.15GBX. The last stock close price is down -7.00% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 223,096 shares of the stock were exchanged, down from an average trading volume of 415,903

Allergy Therapeutics PLC (LON:AGY) had its target price hold steady to 37.00GBX by Numis in a report released 10/10/2016. The new target price indicates a possible upside of 0.74% based on the company's last stock close price.

Previously on 9/26/2016, Numis reported about Allergy Therapeutics PLC (LON:AGY) held steady the target price at 37.00GBX. At the time, this indicated a possible upside of 1.10%.

See Chart Below

Allergy Therapeutics PLC (LON:AGY)

Allergy Therapeutics PLC has a 52 week low of 17.25GBX and a 52 week high of 34.82GBX The company’s market cap is currently 0 GBX.

In addition to Numis reporting its target price, a total of 3 firms have issued a report on the stock. The consensus target price is 64.67GBX with 1 firm rating the stock a strong buy, 1 firm rating the stock a buy, 0 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.

About Allergy Therapeutics PLC (LON:AGY)

Allergy Therapeutics Plc is a United Kingdom-based pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum free products. It provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's business segments are Central Europe, which includes segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes segments, such as Italy and Spain; the United Kingdom, which includes Latin America, and Rest of World. It offers products, such as Pollinex Trees, Pollinex Grasses + Rye and Skin Prick Testing; Diagnostic Products, such as Pollen, Foods, Moulds, Arthropods and Epithelia, and the United Kingdom Special products, including Pollinex Quattro, Tyrosine TU t.o.p, Oralvac Compact, and DAP Penicillin/DAP Amoxicillin/DAP Clavulanic.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *